Nutritional Problems After Lung and Heart Transplantation
Overview
Part 1) Bone health after transplantation – possible influence of vitamin K Part 2) Fat metabolism and endocrine parameters – possible predictors for developement of overweight after transplantation
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Study Primary Completion Date: April 2007
Interventions
- Drug: Vitamin K
- 180 micrograms vitamin K daily
- Drug: Vitamin K
- 2 capsules daily 180 micrograms vitamin K daily or placebo 1 year
Clinical Trial Outcome Measures
Primary Measures
- plasma vitamin K
- Time Frame: 1 year
Secondary Measures
- Bone mineral density
- Time Frame: 1 year
Participating in This Clinical Trial
Inclusion Criteria
- accepted for transplantation Exclusion Criteria:
- not accepted for transplantation
Gender Eligibility: All
Minimum Age: 20 Years
Maximum Age: 70 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Oslo University Hospital
- Collaborator
- Norwegian Foundation for Health and Rehabilitation
- Provider of Information About this Clinical Study
- Liv Forli, Rikshospitalet HF
- Overall Official(s)
- Liv Forli, Dr, Principal Investigator, Oslo University Hospital
- Liv Forli, Dr, Study Director, Oslo University Hospital
- Oystein Bjortuft, MD, Study Chair, Oslo University Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.